mesalamine has been researched along with Cholangiitis, Sclerosing in 18 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The risk of acute pancreatitis in patients with IBD is increased due to the higher incidence of cholelithiasis and drug-induced pancreatitis in this population." | 2.82 | Pancreatic Disorders in Patients with Inflammatory Bowel Disease. ( Bi, Y; Corral, JE; Farraye, FA; Ji, B; Kröner, PT; Lukens, FJ; Montenegro, ML, 2022) |
| "The presence of concomitant primary sclerosing cholangitis (PSC) with inflammatory bowel disease (IBD) represents a distinct disease phenotype that carries a higher risk of colorectal cancer (CRC) than the average IBD patient." | 2.58 | Reviewing the Risk of Colorectal Cancer in Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis. ( Kowdley, KV; Lashner, B; Rao, BB, 2018) |
| "An increased risk of colorectal cancer (CRC) is present also after LT in IBD patients with primary sclerosing cholangitis (PSC)." | 2.50 | Clinical management of inflammatory bowel disease in the organ recipient. ( Indriolo, A; Ravelli, P, 2014) |
| "The comorbidity of Crohn's disease (CD) and primary sclerosing cholangitis (PSC) is uncommon." | 2.48 | Crohn's disease and primary sclerosing cholangitis: a case report and review of the literature. ( Miao, XP; Ouyang, Q; Sun, XN; Wei, H, 2012) |
| "The relative risk of colorectal cancer in ulcerative colitis is increased, however, there're marked geographically differences." | 2.43 | [Inflammatory bowel disease and colorectal cancer]. ( Hagymási, K; Tulassay, Z, 2006) |
| "Up to 3." | 1.48 | Crohn's Disease Behavior and Location is Altered when Associated with Primary Sclerosing Cholangitis. ( Dotan, I; Iny, O; Maharshak, N; Matalon, S; Santo, E; Shibolet, O; Yanai, H, 2018) |
| "Patients with primary sclerosing cholangitis (PSC) and ulcerative colitis (UC) are at an increased risk of colorectal neoplasia, but it is unknown if liver transplantation (LT) alters neoplasia progression." | 1.39 | The fate of indefinite and low-grade dysplasia in ulcerative colitis and primary sclerosing cholangitis colitis before and after liver transplantation. ( Eaton, JE; Imam, M; Loftus, EV; Owens, VL; Pardi, DS; Smyrk, TC; Talwalkar, JA, 2013) |
| "Ulcerative colitis was diagnosed in 77 (97." | 1.38 | The effects of liver transplantation on the clinical course of colitis in ulcerative colitis patients with primary sclerosing cholangitis. ( Choudhary, M; Kiran, RP; Lashner, BA; Navaneethan, U; Remzi, FH; Shen, B; Venkatesh, PG, 2012) |
| "The 25-year cumulative rate of colorectal cancer was 23." | 1.35 | Disease activity and cancer risk in inflammatory bowel disease associated with primary sclerosing cholangitis. ( Beaugerie, L; Chazouilleres, O; Cosnes, J; Poupon, R; Seksik, P; Sokol, H; Tiret, E, 2008) |
| "Ursodeoxycholic acid (UDCA) treatment for primary sclerosing cholangitis (PSC) has been considered a rational therapy, though its effectiveness in the clinical course is still open to discussion." | 1.31 | Paradoxical progression of biliary strictures against recovery of biochemical parameters under ursodeoxycholic acid treatment in a case of primary sclerosing cholangitis with ulcerative colitis. ( Kikuchi, S; Kisara, N; Komatsu, K; Maruhama, Y; Shimosegawa, T; Toyota, T; Uchi, M; Ueno, Y, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.56) | 18.2507 |
| 2000's | 4 (22.22) | 29.6817 |
| 2010's | 12 (66.67) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Montenegro, ML | 1 |
| Corral, JE | 1 |
| Lukens, FJ | 1 |
| Ji, B | 1 |
| Kröner, PT | 1 |
| Farraye, FA | 1 |
| Bi, Y | 1 |
| Filipec Kanizaj, T | 1 |
| Mijic, M | 1 |
| Rao, BB | 1 |
| Lashner, B | 1 |
| Kowdley, KV | 1 |
| Iny, O | 1 |
| Yanai, H | 1 |
| Matalon, S | 1 |
| Santo, E | 1 |
| Shibolet, O | 1 |
| Dotan, I | 2 |
| Maharshak, N | 1 |
| Bar Yehuda, S | 1 |
| Axlerod, R | 1 |
| Toker, O | 1 |
| Zigman, N | 1 |
| Goren, I | 1 |
| Mourad, V | 1 |
| Lederman, N | 1 |
| Cohen, N | 1 |
| Matz, E | 1 |
| Dushnitzky, D | 1 |
| Gavish, M | 1 |
| Borovsky, N | 1 |
| Schwarts, D | 1 |
| Turner, D | 1 |
| Stokkeland, K | 1 |
| Höijer, J | 1 |
| Bottai, M | 1 |
| Söderberg-Löfdal, K | 1 |
| Bergquist, A | 1 |
| Sebastian, S | 1 |
| Hernández, V | 1 |
| Myrelid, P | 1 |
| Kariv, R | 1 |
| Tsianos, E | 1 |
| Toruner, M | 1 |
| Marti-Gallostra, M | 1 |
| Spinelli, A | 1 |
| van der Meulen-de Jong, AE | 1 |
| Yuksel, ES | 1 |
| Gasche, C | 1 |
| Ardizzone, S | 1 |
| Danese, S | 1 |
| Eaton, JE | 1 |
| Smyrk, TC | 1 |
| Imam, M | 1 |
| Pardi, DS | 1 |
| Loftus, EV | 1 |
| Owens, VL | 1 |
| Talwalkar, JA | 1 |
| Indriolo, A | 1 |
| Ravelli, P | 1 |
| Sokol, H | 1 |
| Cosnes, J | 1 |
| Chazouilleres, O | 1 |
| Beaugerie, L | 1 |
| Tiret, E | 1 |
| Poupon, R | 1 |
| Seksik, P | 1 |
| Kevans, D | 1 |
| Greene, J | 1 |
| Galvin, L | 1 |
| Morgan, R | 1 |
| Murray, FE | 1 |
| Pan, A | 1 |
| Schlup, M | 1 |
| Lubcke, R | 1 |
| Schultz, M | 1 |
| Navaneethan, U | 1 |
| Choudhary, M | 1 |
| Venkatesh, PG | 1 |
| Lashner, BA | 1 |
| Remzi, FH | 1 |
| Shen, B | 1 |
| Kiran, RP | 1 |
| Miao, XP | 1 |
| Sun, XN | 1 |
| Wei, H | 1 |
| Ouyang, Q | 1 |
| Vetter, C | 1 |
| Hagymási, K | 1 |
| Tulassay, Z | 1 |
| Fornaciari, G | 1 |
| Maccari, S | 1 |
| Borgatti, PP | 1 |
| Rustichelli, R | 1 |
| Amelio, N | 1 |
| Lattuada, I | 1 |
| Plancher, AC | 1 |
| Komatsu, K | 1 |
| Shimosegawa, T | 1 |
| Kikuchi, S | 1 |
| Uchi, M | 1 |
| Maruhama, Y | 1 |
| Kisara, N | 1 |
| Ueno, Y | 1 |
| Toyota, T | 1 |
8 reviews available for mesalamine and Cholangiitis, Sclerosing
| Article | Year |
|---|---|
Pancreatic Disorders in Patients with Inflammatory Bowel Disease.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Autoimmune Pancreatitis; Azathioprin | 2022 |
Inflammatory bowel disease in liver transplanted patients.
Topics: Algorithms; Anastomosis, Surgical; Cholangitis, Sclerosing; Colonoscopy; Colorectal Neoplasms; Femal | 2017 |
Reviewing the Risk of Colorectal Cancer in Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis.
Topics: Cholangitis, Sclerosing; Colonoscopy; Colorectal Neoplasms; Humans; Inflammatory Bowel Diseases; Liv | 2018 |
Colorectal cancer in inflammatory bowel disease: results of the 3rd ECCO pathogenesis scientific workshop (I).
Topics: Age of Onset; Anticarcinogenic Agents; Cholangitis, Sclerosing; Colitis, Ulcerative; Colorectal Neop | 2014 |
Clinical management of inflammatory bowel disease in the organ recipient.
Topics: Azathioprine; Cholangitis, Sclerosing; Colectomy; Colorectal Neoplasms; End Stage Liver Disease; Gra | 2014 |
Fulminant ulcerative colitis despite maximal immunosuppression following liver transplantation: a case report and literature review.
Topics: Cholangitis, Sclerosing; Colectomy; Colitis, Ulcerative; Drug Therapy, Combination; Female; Humans; | 2011 |
Crohn's disease and primary sclerosing cholangitis: a case report and review of the literature.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; CA-19-9 Antigen; Cholagogues and Choleretics; Cholan | 2012 |
[Inflammatory bowel disease and colorectal cancer].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cholangitis, Sclerosing; Colitis, Ulcerative; Colonoscopy; | 2006 |
10 other studies available for mesalamine and Cholangiitis, Sclerosing
| Article | Year |
|---|---|
Crohn's Disease Behavior and Location is Altered when Associated with Primary Sclerosing Cholangitis.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Case-Control Studies; Cholangitis, Sclerosing; Colon | 2018 |
The Association of Inflammatory Bowel Diseases with Autoimmune Disorders: A Report from the epi-IIRN.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Autoimmune Diseases; Biological Products; Case | 2019 |
Statin Use Is Associated With Improved Outcomes of Patients With Primary Sclerosing Cholangitis.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cholagogues and Choleretics; Cholangit | 2019 |
The fate of indefinite and low-grade dysplasia in ulcerative colitis and primary sclerosing cholangitis colitis before and after liver transplantation.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Cholangitis, Sclerosing; Colitis, Ulcerative; | 2013 |
Disease activity and cancer risk in inflammatory bowel disease associated with primary sclerosing cholangitis.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Case-Control Studies; Cholangitis, Scler | 2008 |
Mesalazine-induced bronchiolitis obliterans organizing pneumonia (BOOP) in a patient with ulcerative colitis and primary sclerosing cholangitis.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Cholangitis, Sclerosing; Colitis, Ulcerative; C | 2011 |
The effects of liver transplantation on the clinical course of colitis in ulcerative colitis patients with primary sclerosing cholangitis.
Topics: Adult; Aged; Cholangitis, Sclerosing; Cohort Studies; Colectomy; Colitis, Ulcerative; Female; Follow | 2012 |
[Chronic inflammatory bowel diseases. Recurrence prevention = carcinoma prevention?].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cholangitis, Sclerosing; Colitis, Ulcerative; | 2005 |
Nephrotic syndrome from 5-ASA for ulcerative colitis? Complicated by carcinoma of the colon and sclerosing cholangitis.
Topics: Adult; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Cholangitis, Sclerosing; Colit | 1997 |
Paradoxical progression of biliary strictures against recovery of biochemical parameters under ursodeoxycholic acid treatment in a case of primary sclerosing cholangitis with ulcerative colitis.
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Autoimmune Diseases; Betame | 2000 |